Medication adherence among recipients with chronic diseases enrolled in a state medicaid program

Population Health Management

Volumn 15, Issue 5, 2012, Pages 253-260

  Khanna, Rahul ^a   Pace, Patrick F ^a   Mahabaleshwarkar, Rohan ^a   Basak, Ram Sankar ^a   Datar, Manasi ^a   Banahan, Benjamin F ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ALDOSTERONE RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILE ACID SEQUESTRANT; CALCIUM CHANNEL BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DIURETIC AGENT; ETIRACETAM; FIBRIC ACID DERIVATIVE; HORMONE RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN DERIVATIVE; MONOAMINE OXIDASE INHIBITOR; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; PERIPHERAL VASODILATING AGENT; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SODIUM CHANNEL BLOCKING AGENT; TETRACYCLIC ANTIDEPRESSANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ADULT; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; EMERGENCY CARE; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; EPILEPSY; FEMALE; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH EDUCATION; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAID; PATIENT COMPLIANCE; RHEUMATOID ARTHRITIS; UNITED STATES;

ADULT; CHRONIC DISEASE; DEPRESSION; DIABETES MELLITUS; EPILEPSY; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; LOGISTIC MODELS; MALE; MEDICAID; MEDICATION ADHERENCE; MIDDLE AGED; MISSISSIPPI; PROGRAM EVALUATION; UNITED STATES; YOUNG ADULT;

EID: 84866328554     PISSN: 19427891     EISSN: 19427905     Source Type: Journal    
DOI: 10.1089/pop.2011.0069     Document Type: Article

References (41)

1. Kaiser Family Foundation. Prescription drug trends fact sheet - May 2010 update. Available at: http://www.kff.org/ rxdrugs/upload/3057-08.pdf. Accessed July 30, 2011.
2. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497.
3. Balkrishnan R. The importance of medication adherence in improving chronic disease related outcomes. Med Care. 2005;43:517-520.
4. Martin BC, Wiley-Exley EK, Richards S, Domino ME, Carey TS, Sleath BL. Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother. 2009;43:36-44.
5. Cutler DM, Long G, Berndt ER, et al. The value of antihypertensive drugs: A perspective on medical innovation. Health Aff (Millwood). 2007;26:97-110.
6. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and longterm mortality after acute myocardial infarction. JAMA. 2007;297:177-186.
7. Faught E, Duh MS, Weiner JR, Gue'rin A, Cunnington MC. Nonadherence to antiepileptic drugs and increased mortality: Findings from the RANSOM Study. Neurology. 2008; 71:1572-1578.
8. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006;166: 1836-1841.
9. Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333:15.
10. Hovinga CA, Asato MR, Manjunath R, et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy Behav. 2008;13:316-322.
11. Smith DL. Compliance packaging: A patient education tool. Am Pharm. 1989;NS29:42-45,49-53.
12. Hepke KL, Martus MT, Share DA. Costs and utilization associated with pharmaceutical adherence in a diabetic population. Am J Manag Care. 2004;10:144-151.
13. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521-530.
14. Bender BG, Rand C. Medication non-adherence and asthma treatment cost. CurrOpinAllergyClin Immunol. 2004;4:191-195.
15. New England Healthcare Institute. Thinking outside the pillbox: A system-wide approach to improving patient medication adherence for chronic disease. Available at: http:// www.nehi.net/publications/44/thinking-outside- the-pillbox-a-systemwide-approach-to-improving-patient-medication-adherence-for- chronic-disease. Accessed July 31, 2011.
16. Krueger KP, Berger BA, Felkey B. Medication adherence and persistence: A comprehensive review. Adv Ther. 2005;22:313- 356.
17. Wamala S, Merlo J, Bostrom G, Hogstedt C, Agren G. Socioeconomic disadvantage and primary non-adherence with medication in Sweden. Int J Qual Health Care. 2007;19:134-140.
18. Faught RE, Weiner JR, Gue'rin A, Cunnington MC, Duh MS. Impact of nonadherence to antiepileptic drugs on healthcare utilization and costs: Findings from the RANSOM study. Epilepsia. 2009;50:501-509.
19. Weiss BD, Blanchard JS, McGee DL, et al. Illiteracy among Medicaid recipients and its relationship to health care costs. J Health Care Poor Underserved. 1994;5:99-111.
20. Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity: How much, and who's paying? Health Aff (Millwood). 2003; Suppl Web Exclusives:W3-219-226.
21. Cunningham PJ. Affording Prescription Drugs: Not Just a Problem for the Elderly. Research Report No. 5. Washington, DC: Center for Studying Health System Change; 2002.
22. Bagchi AD, Esposito D, Kim M, Verdier J, Bencio D. Utilization of, and adherence to, drug therapy among Medicaid beneficiaries with congestive heart failure. Clin Ther. 2007;29:1771-1783.
23. Shenolikar RA, Balkrishnan R, Camacho FT, Whitmire JT, Anderson RT. Comparison of medication adherence and associated health care costs after introduction of pioglitazone treatment in African Americans versus all other races in patients with type 2 diabetes mellitus: A retrospective data analysis. Clin Ther. 2006;28:1199-1207.
24. Gilmer TP, Dolder CR, Lacro JP, et al. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry. 2004;161:692-699.
25. Shaya FT, Du D, Gbarayor CM, Frech-Tamas F, Lau H, Weir MR. Predictors of compliance with antihypertensive therapy in a high-risk Medicaid population. J Natl Med Assoc. 2009; 101:34-39.
26. Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28:437-443.
27. Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: A proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40:1280-1288.
28. Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15: 565-574.
29. Yeaw J, Benner JS, Walt JG, Sian S, Smith DB. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm. 2009;15:728-740.
30. D'Hoore W, Bouckaert A, Tilguin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol. 1996;49:1429-1433.
31. Kaiser Family Foundation. Optimizing Medicaid enrollment: perspectives on strengthening Medicaid's reach under health care reform. Available at http://www.kff.org/ healthreform/upload/8068.pdf. Accessed August 1, 2011.
32. Gencarelli DM. Medicaid prescription drug coverage: state efforts to control costs. NHPF Issue Brief. 2003;790:1-17.
33. Abouzaid S, Jutkowitz E, Foley KA, Pizzi LT, Kim E, Bates J. Economic impact of prior authorization policies for atypical antipsychotics in the treatment of schizophrenia. Popul Health Manag. 2010;13:247-254.
34. Zhang Y, Adams AS, Ross-Degnan D, Zhang F, Soumerai SB. Effects of prior authorization on medication discontinuation among Medicaid beneficiaries with bipolar disorder. Psychiatr Serv. 2009;60:520-527.
35. Soumerai SB, Ross-Degnan D, Avorn J, McLaughlin T, Choodnovskiy I. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med. 1991;325:1072-1077.
36. Cantrell CR, Eaddy MT, Shah MB, Regan TS, Sokol MC. Methods for evaluating patient adherence to antidepressant therapy: A real-world comparison of adherence and economic outcomes. Med Care. 2006;44:300-303.
37. Mississippi State Department of Health Office of Rural Health. State rural health plan. Available at: http:// www.msdh.state.ms.us/msdhsite/-static/ resources/66.pdf. Accessed July 9, 2011.
38. Ruiz R. The healthiest and unhealthiest states. Available at http://www.forbes.com/2009/11/16/unhealthy-healthystates- lifestyle-health- states-top-chart.html?partnerpyahoo health. Accessed August 1, 2011.
39. Prescription Policy Choices. Prescription drug caps - An ineffective policy that harms patients. Available at: http:// www.policychoices.org/ documents/DrugCap-FastFacts.pdf. Accessed July 6, 2011.
40. Kaiser Family Foundation. Women's access to health care. Available at: http://www.kff.org/womenshealth/upload/ Women-and-Health-Care-A-National- Profile-Key-Findingsfrom- the-Kaiser-Women-s-Health-Survey-Chapter-4.pdf. Accessed July 10, 2011.
41. Cutler DM, Everett W. Thinking outside the pillbox - Medication adherence as a priority for health care reform. N Engl J Med. 2010;362:1553-1555.